glp 1 agonist and heart failure GLP-1 Receptor Agonists in Results of cardiovascular outcomes trials
Description
Retatrutide NAFLD - Phase 2 Trial Results in Subset of Patients with Obesity and NAFLD
doi: 10.1038/s41574-024-00951-7
obesity, hypertension, smoking, dyslipidaemia or albuminuria)
placebo in people with type 2 diabetes insufficiently controlled on metformin (GetGoal-F1)
Role of anti-diabetic medications in the management of MASLD
